“I have lung cancer?” I whispered to my doctor in disbelief over the phone. It felt like a secret between us. “I am afraid so,” he replied definitively.
When I hung up, the room fell silent, like the calm before a storm. I hurried to my husband’s home office, seeking cover and clarity. “It’s cancer,” I admitted, struggling to process the words.
My husband, Jimmy, took me in his arms and said, “Helene, I am sorry to tell you, but you’re nothing special.” His words were not dismissive. After 35 years of marriage, he was trying to provide comfort in his logical way. Though it wasn’t what I wanted to hear, I realized that his perspective had some truth.
Lung cancer is the second most common type of cancer. According to the American Cancer Society, over 200,000 people are diagnosed each year. Most cases are discovered after the cancer has spread, making early detection crucial for potential cures.
Four weeks before my diagnosis, I was navigating New York’s Central Park for my annual checkup. Full of energy after a gym session, I felt great at 63. My age didn’t stop me from anything, except buying low-rise jeans.
Due to my age, my checkup included extra tests, like a chest X-ray. My doctor compares these for all his patients over 50 every five years. During the exam, a new white shadow appeared on my right lung.
Though my doctor felt it wasn’t alarming, possibly scar tissue or benign, he ordered a CT scan as a precaution. Apart from this anomaly, I seemed healthy. But after further scans and a biopsy, the phone call confirmed cancer.
Between diagnosis and surgery, the days felt endless. I told few people and might have kept it from my kids, but our location-sharing app revealed I spent my wedding anniversary at a hospital. When they called, teary and asking if I was okay, I faced the reality.
My husband’s words helped me during these tough moments: “You’re nothing special.” This mantra allowed me to release personal feelings of injustice. Instead of “Why me?” the real question became “Why not me?” Research shows nearly 20% of U.S. women diagnosed with lung cancer are nonsmokers. I was one of 22,000, nothing unique.
The experience forced me to confront human vulnerability. Our bodies, while miraculous, can fail. I hadn’t done anything wrong. Anyone with lungs is at risk for lung cancer. The notion of complete control over health is misleading.
Before my lobectomy to remove part of my lung, my surgeon asked if I had any questions. Early in the morning, my husband jokingly checked if the doctor had enough coffee. After a laugh, the doctor mentioned another procedure earlier that day and a cancer panel in South Korea.
After he left, my husband reiterated, “See, you’re nothing special.” A nurse overheard and remarked on his humor, prompting my first laugh in weeks.
Two weeks post-surgery, my doctor shared good news. My cancer was detected early and hadn’t spread. No further treatment like chemotherapy or radiation was necessary. With encouragement to enjoy life, I left his office with a smile.
Eight months later, life doesn’t feel ominous. My mantra continues guiding me. At work, I embrace competition rather than take rejection personally. A winter cough no longer alarms me; illness can affect anyone.
At my first six-month checkup, I wasn’t calm. Waiting for the doctor, I reflected on the increase in lung cancer diagnoses. The number of cases among women has risen by 6% since 2019. Early detection and therapies improve survivorship, making outcomes less extraordinary.
Helene Rosenthal resides in Miami, exploring themes of relationships through her writing. Her essays feature in various reputable publications, including The New York Times and The Guardian.
All opinions in this article are the author’s own.
Have a personal essay to share with Newsweek? Send it to [email protected].

Cancer Death Rates Decline in the U.S., But Disparities Remain
Supreme Court Ruling Limits Religious Freedom Protections for Federal Prisoners
DOJ Sues UCLA Over Alleged Discrimination Against Jewish and Israeli Students
Search Continues for Missing Giraffe in Texas
COVID-19 Vaccine Study Highlights Effectiveness Amid Controversy
Life Inside Biocontainment and Updates on Covid-19 Vaccine Policies